Log in to save to my catalogue

Genetic evidence from Mendelian randomization links CD40 levels to increased risk of estrogen recept...

Genetic evidence from Mendelian randomization links CD40 levels to increased risk of estrogen recept...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_35b125d5aa3840d9aa7dbbf6b1444c87

Genetic evidence from Mendelian randomization links CD40 levels to increased risk of estrogen receptor-positive breast cancer

About this item

Full title

Genetic evidence from Mendelian randomization links CD40 levels to increased risk of estrogen receptor-positive breast cancer

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2025-04, Vol.15 (1), p.14892-9, Article 14892

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

This study uses Mendelian randomization (MR) to investigate the causal roles of CD40 and CD40L in BC.Data from genome-wide association studies (GWAS) on BC (overall, ER-positive, and ER-negative subtypes) and CD40/CD40L levels were obtained from the IEU database. Causal associations were assessed using the inverse-variance weighted (IVW) method, wi...

Alternative Titles

Full title

Genetic evidence from Mendelian randomization links CD40 levels to increased risk of estrogen receptor-positive breast cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_35b125d5aa3840d9aa7dbbf6b1444c87

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_35b125d5aa3840d9aa7dbbf6b1444c87

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-025-99410-0

How to access this item